Is Hologic Inc (HOLX) overvalued? · P/E 32, rev $4.10B
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether Hologic Inc (HOLX) looks expensive on cached numbers — not a short thesis.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HOLX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HOLX stock page for the full model, not this heading.
Not investment advice.